Explore

Trendline Trendline
AbCellera to Present Phase 1 Data for ABCL635 in Upcoming Earnings Call

AbCellera to Present Phase 1 Data for ABCL635 in Upcoming Earnings Call

AbCellera to Present Phase 1 Data for ABCL635 in Upcoming Earnings Call
Trendline Trendline
Gilead and Arcus End Cancer Drug Trials Following Futility Analysis

Gilead and Arcus End Cancer Drug Trials Following Futility Analysis

Gilead and Arcus End Cancer Drug Trials Following Futility Analysis
Trendline Trendline
Merck Shares Decline Following Unsuccessful Kidney Cancer Drug Trial

Merck Shares Decline Following Unsuccessful Kidney Cancer Drug Trial

Merck Shares Decline Following Unsuccessful Kidney Cancer Drug Trial
Trendline Trendline
OmniAb to Announce First Quarter 2026 Financial Results in Upcoming Conference Call

OmniAb to Announce First Quarter 2026 Financial Results in Upcoming Conference Call

OmniAb to Announce First Quarter 2026 Financial Results in Upcoming Conference Call
Trendline Trendline
UCB Acquires Neurona Therapeutics in $1.15 Billion Deal to Advance Epilepsy Treatment

UCB Acquires Neurona Therapeutics in $1.15 Billion Deal to Advance Epilepsy Treatment

UCB Acquires Neurona Therapeutics in $1.15 Billion Deal to Advance Epilepsy Treatment
Trendline Trendline
AstraZeneca's Tozorakimab Shows Promise in COPD Phase 3 Trials, Paving Way for Market Entry

AstraZeneca's Tozorakimab Shows Promise in COPD Phase 3 Trials, Paving Way for Market Entry

AstraZeneca's Tozorakimab Shows Promise in COPD Phase 3 Trials, Paving Way for Market Entry
Trendline Trendline
Novo Nordisk Advances Sickle Cell Drug Etavopivat Towards Regulatory Filings

Novo Nordisk Advances Sickle Cell Drug Etavopivat Towards Regulatory Filings

Novo Nordisk Advances Sickle Cell Drug Etavopivat Towards Regulatory Filings
Trendline Trendline
Arrowhead Pharmaceuticals to Announce Fiscal 2026 Q2 Results via Webcast

Arrowhead Pharmaceuticals to Announce Fiscal 2026 Q2 Results via Webcast

Arrowhead Pharmaceuticals to Announce Fiscal 2026 Q2 Results via Webcast
Trendline Trendline
Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments

Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments

Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments
Trendline Trendline
Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation

Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation

Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation
Trendline Trendline
Asahi Kasei Initiates Phase I Trial for New Peptide Targeting Autoimmune Diseases

Asahi Kasei Initiates Phase I Trial for New Peptide Targeting Autoimmune Diseases

Asahi Kasei Initiates Phase I Trial for New Peptide Targeting Autoimmune Diseases
Trendline Trendline
Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Following Trial Discontinuation

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Following Trial Discontinuation

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Claims Following Trial Discontinuation